Some dispensaries owners warn that moving the plant to a Schedule III classification could open the cannabis market to larger retail pharmacies who already have the capacity and licensure to dispense Schedule III drugs with a prescription.

A move by the Biden Administration to change how marijuana is treated by federal authorities was met with cautious approval by Massachusetts state regulators, cannabis sellers, and national marijuana…